However, it is only recently that SAA has been proposed as a potentially useful biomarker to monitor patients harbouring human tumours including gastric and nasopharyngeal cancer (Cho et al, 2004; Chan et al, 2007). The gene discussed is SAA1; the disease is neoplasm.